Yorkshire-based AI company IntelliAM has appointed Dr Keith Harris as its non-executive director and chairman-elect.
The Aquis-listed firm, which is currently scaling its AI-powered solutions across global industrial sectors, says the appointment marks a key milestone in its growth strategy.
It specialises in AI and machine learning for the manufacturing sector and counts six of the world’s top 12 food and drink producers – including Muller, Mars, ADM, Weetabix and Hovis – as customers.
Dr Harris, who will formally take on the role on 1st July 2025, has over 35 years of experience advising on complex cross-border M&A, equity and debt capital markets transactions and corporate leadership.
He has held senior roles at Morgan Grenfell, Drexel Burnham and also served as chief executive of HSBC Investment Bank.
His other former roles include being the principal owner and chairman of Seymour Pierce Holdings and he has held a number of high-profile board positions, including chairman of Wembley National Stadium, and the Football League.
He currently serves as chairman of NASDAQ-listed gene therapy company MeiraGTx and executive chairman of Global Connectivity Plc, quoted on AQSE.
“We are delighted to welcome Keith to the board,” said Tom Clayton, CEO of IntelliAM.
“His extraordinary track record in capital markets and board leadership will bring enormous value to IntelliAM as we deepen our relationships with institutional investors and pursue our strategic growth initiatives.”
Dr Harris added: “IntelliAM is delivering real transformation in a vital sector through the intelligent application of AI.
“I look forward to working with Tom and the board to support the company’s ambitions and help realise its significant market potential.”
The news follows a trio of appointments to the AI firm’s leadership team, seeing Jane Robinson join as VP of business development, Ian Wild as VP of product and Owain Lewis as VP of data engineering.